Sumner Michael John

CIK 00019367991 companyPLYMOUTH MEETING, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001936799

Recent Transactions

32 trades

Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2026-03-04+29,608→ 29,608 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2026-03-04+36,832→ 36,832 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2026-02-26−5,010→ 5,009 total
Tax Payment
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2026-02-26$1.79/sh−3,903→ 30,507 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2026-02-26+11,550→ 34,410 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2026-02-26−11,550→ 23,100 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2026-02-26+5,010→ 22,860 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2025-06-30−2,916→ 0 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2025-06-30+2,916→ 17,850 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2025-05-20+28,350→ 28,350 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2025-05-20+35,100→ 35,100 total
Tax Payment
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2025-05-15$1.95/sh−680→ 14,934 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2025-05-15−2,385→ 2,385 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2025-05-15+2,385→ 15,614 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2025-02-27+34,650→ 34,650 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2025-02-27+42,900→ 42,900 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2025-02-26−5,010→ 10,019 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2025-02-26+5,010→ 13,229 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2024-12-18+5,708→ 5,708 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2024-12-18+4,292→ 4,292 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2024-06-30+2,917→ 8,219 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2024-06-30−2,917→ 2,916 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2024-05-15−2,386→ 4,770 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2024-05-15+2,386→ 5,302 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2024-02-28+18,750→ 18,750 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2024-02-28+15,029→ 15,029 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock
2023-06-30+35,000→ 35,000 total
Exercise/Conversion
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2023-06-30−35,000→ 70,000 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2023-05-15+85,878→ 85,878 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Option
2023-02-27+112,500→ 112,500 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Restricted Stock Unit
2022-06-30+105,000→ 105,000 total
Award
INOVIO PHARMACEUTICALS, INC.$INO
Common Stock Options
2022-06-30+160,000→ 160,000 total

Companies

INOVIO PHARMACEUTICALS, INC.
Chief Medical Officer
$INO

Recent Filings

Address

660 W. GERMANTOWN PIKE SUITE 110

PLYMOUTH MEETING, PA, 19462

View on SEC.gov